Screener
Ocular Therapeutix OCUL Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
Based on the most recent quarter.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
FAQ
- What is Ocular Therapeutix's debt-to-equity?
- Ocular Therapeutix (OCUL) reported debt-to-equity of 0.1× in Q1 2026.
- How has Ocular Therapeutix's debt-to-equity changed year-over-year?
- Ocular Therapeutix's debt-to-equity decreased by 52.3% year-over-year, from 0.3× to 0.1×.
- What is the long-term trend for Ocular Therapeutix's debt-to-equity?
- Over 5 years (2020 to 2025), Ocular Therapeutix's debt-to-equity has grown at a -19.1% compound annual growth rate (CAGR), from 0.3× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Ocular Therapeutix's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude